Legal & General Group Plc - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,240,349
+47.1%
83,189
+8.1%
0.00%
Q2 2023$843,244
+164.3%
76,957
+110.4%
0.00%
Q1 2023$319,022
+1287.1%
36,585
+401.0%
0.00%
Q1 2022$23,000
+21.1%
7,302
+31.4%
0.00%
Q4 2021$19,000
-5.0%
5,5580.0%0.00%
Q3 2021$20,000
-16.7%
5,5580.0%0.00%
Q2 2021$24,000
-44.2%
5,558
-41.2%
0.00%
Q1 2021$43,000
-20.4%
9,4570.0%0.00%
Q4 2020$54,000
+22.7%
9,457
+54.9%
0.00%
Q3 2020$44,000
+46.7%
6,106
-28.2%
0.00%
Q2 2020$30,000
+50.0%
8,503
-36.7%
0.00%
Q1 2020$20,000
-37.5%
13,434
-18.1%
0.00%
Q4 2019$32,000
-54.9%
16,404
+19.3%
0.00%
Q3 2019$71,000
-27.6%
13,7460.0%0.00%
Q2 2019$98,000
-30.0%
13,746
+29.7%
0.00%
Q1 2019$140,000
+79.5%
10,595
+6.6%
0.00%
Q4 2018$78,000
-29.1%
9,9410.0%0.00%
Q3 2018$110,000
-17.9%
9,9410.0%0.00%
Q2 2018$134,0009,9410.00%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders